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ABSTRACT
Many studies reported that antioxidants and dietary supplements increase tumour progress and reduce survival. 
Hyperthermia is an adjuvant treatment to sensitise cancer cells for radio- or chemotherapy. The current study was 
carried out to determine the effects of berberine chloride and hyperthermia on bone cancer cells. MG-63 osteosarcoma 
cells were treated with hyperthermia (39, 43 and 45°C, respectively) for 1 h. Then, the cells were treated with a low 
toxic dose of berberine chloride (80 µg/mL). After that, all treated groups were recovered at 37°C for 24 h. Finally, all 
groups were treated with hyperthermia (39, 43 and 45°C) for the second time (1 h) and were recovered for 3 h at 37°C. 
Cells exposed to hyperthermia without treatment of berberine chloride were used as hyperthermia control. Cells treated 
with 80 µg/mL of berberine at 37°C served as berberine control and cells incubated at 37°C were used as an untreated 
control. All treated groups showed significant apoptosis compared to the control group (p<0.05) except 39°C. On the 
other hand, mild hyperthermia treatment (39°C) resulted in a reduction of berberine-induced apoptosis (p<0.001). 
Severe and moderate hyperthermia did not show a significant increase in the rate of apoptosis compared to berberine 
treated cells. Mild hyperthermia treatment can effectively reduce berberine cytotoxicity and implying negative effects 
on cancer therapy.
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ABSTRAK
Banyak kajian melaporkan bahawa antioksidan dan makanan kesihatan meningkatkan kemajuan tumor dan mengurangkan 
survival. Hipertermia merupakan rawatan menormalkan untuk menyedarkan sel-sel kanser untuk radio - atau kemoterapi. 
Kajian ini telah dijalankan untuk menentukan kesan berberina klorida dan hipertermia ke atas sel kanser tulang. Sel 
osteosarkoma MG-63 dirawat dengan hipertermia (39, 43 dan 45°C, masing-masing) untuk 1 jam. Kemudian, sel dirawat 
dengan dos rendah toksik berberina klorida (80 µg/mL). Selepas itu, semua kumpulan yang dirawat telah pulih pada 
37°C selama 24 jam. Akhirnya, semua kumpulan telah dirawat dengan hipertermia (39, 43 dan 45°C) kali kedua (1 
jam) dan telah pulih untuk 3 jam pada 37°C. Sel yang terdedah kepada hipertermia tanpa rawatan berberina klorida 
telah digunakan sebagai kawalan hipertermia. Sel yang dirawat dengan 80 µg/mL berberina pada 37°C digunakan 
sebagai berberina kawalan dan sel yang dieram pada 37°C telah digunakan sebagai kawalan yang tidak dirawat. Semua 
kumpulan yang dirawat menunjukkan kesignifikanan apoptosis berbanding dengan kumpulan kawalan (p<0.05) kecuali 
pada 39°C. Selain itu, rawatan hipertermia ringan (39°C) telah mengurangkan apoptosis aruhan berberina (p<0.001). 
Hipertermia teruk dan sederhana tidak menunjukkan peningkatan yang ketara dalam kadar apoptosis berbanding dengan 
sel berberina yang dirawat. Rawatan hipertermia ringan berkesan boleh mengurangkan kesitotoksikan berberina, 
membayangkan kesan negatif terhadap terapi kanser.
Kata kunci: Apoptosis; berberina klorida; hipertermia; osteosarkoma
INTRODUCTION
Several studies have shown that exposure to hyperthermia 
results in increased apoptosis and reduced cellular viability 
in several mammalian cells (Aisha et al. 2012; Lv et al. 
2013; Rong et al. 2000; Shellman et al. 2008; Trieb et al. 
2007). Osteosarcoma, with an incidence of 0.03-0.2 per 
100 000 per year, represents the most common primary 
malignant bone tumour, which arises predominantly 
from the metaphysis of the long bones of adolescents and 
young adults (Hogendoorn et al. 2010; López-Martínez 
et al. 2012).
 Chemo- or radiotherapy cancer treatments are highly 
demanding on the patient’s body. As such, some patients 
may use supplements like micronutrients (vitamins or 
polyphenols) to reduce the bystander effects of the therapy. 
According to Groeber (2009), approximately 60% of all 
cancer patients take supplements during their therapy 
without informing their oncologists. Sayin et al. (2014) 
1098 
found that supplementing the diet with vitamin E and the 
antioxidant N-acetylcysteine (NAC) results in a marked 
increase in tumour progression and reduces survival in a 
mouse model of B-RAF- and K-RAS-induced lung cancer. 
Additionally, low doses of dietary antioxidants may 
enhance some cancer cells proliferation (ATBCCPSG 1994; 
Jha et al. 2012; Prasad et al. 2001).
 Hyperthermia is used in combination with 
chemotherapy in several types of cancer including 
osteosarcomas, breast cancer, nasopharyngeal cancer, 
colorectal cancer, lung cancer, carcinoma of the oesophagus, 
bladder cancer and ovarian cancer (Gori et al. 2005; Hua 
et al. 2011; Kubota et al. 1984; Sugimachi et al. 1988; 
Tancredi et al. 2011; Verwaal et al. 2003; Yamamoto et 
al. 2012). This may be contributed by the enhancement 
of the oxygenation of otherwise hypoxic tumours, which 
led to increased susceptibility of the tumours to treatment 
(Hurwitz 2010; Matsuzaki et al. 2004). Furthermore, cells 
exposed to high-temperature will incur irreparable damage 
and initiate cell death (Hurwitz 2010).
 Many studies are investigating the pharmacological 
effects of berberine. Berberine possesses anticancer, 
antimicrobial, antidiabetic, anti-oxidative, anti-
inflammatory, and anticancer properties (Kuo et al. 2004; 
Park et al. 2015; Thirupurasundari et al. 2009; Wu et al. 
2012; Yu et al. 2005). However, little is known about 
its effect on osteosarcoma cells, especially at low dose 
and in combination with hyperthermia. Therefore, the 
present study aimed to investigate the apoptotic effects 
of berberine chloride and hyperthermia separately and 
combined against human osteoblast-like-osteosarcoma 
cells MG-63. The regulation of heat shock proteins (HSPs) 
under hyperthermia and their possible involvement in 
attenuation of cytotoxicity of hyperthermia and berberine 
chloride were also investigated.
MATERIALS AND METHODS
Osteoblast-like-osteosarcoma cells MG-63 were purchased 
from the American Type Culture Collection (ATCC, 
Manassas, VA, USA). Foetal bovine serum (FBS), phosphate 
buffered saline (PBS), DMEM/F12 medium, accutase, Trypan 
blue dye, and Penicillin-Streptomycin (pen-strep) were 
obtained from GIBCO-BRL Life Technologies (New York, 
USA). Berberine chloride was obtained from Sigma-Aldrich 
Corporation (St. Louis, MO, USA). The RNeasy Mini kit 
and Sensiscripts RT kit were obtained from Qiagen (Hilden, 
Germany).
CELL CULTURE
Six groups of cells were treated with hyperthermia for 
1 h: Two groups at mild, two at moderate and two at 
severe hyperthermia (39, 43 and 45°C, respectively). 
After finishing this session of hyperthermia, a low toxic 
dose of berberine chloride (80 µg/mL) was selected 
for treating one group of mild, moderate and severe 
hyperthermia (combination). After that, all treated groups 
were recovered at 37°C for 24 h. Then, all groups were 
treated at hyperthermia (39, 43 and 45°C) for the second 
time (1 h) and were recovered for 3 h at 37°C. Cells were 
incubated at 37°C with medium and DMSO (< 1%) as a 
vehicle solvent as an untreated control. To show the effect 
of berberine chloride, another group was treated with 80 
µg/mL of berberine and left for the same period at 37°C.
TRYPAN BLUE EXCLUSION ASSAY
Berberine chloride was dissolved in DMSO. Cells were 
seeded in t-25 flask at a density of 1×104/cm2 and 
treated with several doses of berberine chloride (40, 
80,120,160 and 200 µg/mL) for 24 h. In all groups, the 
final concentration of DMSO was less than 1%. The control 
group incubated with DMSO and medium. The cells were 
harvested, washed with cold PBS. For each treatment, the 
cells were counted on a haemocytometer with an equal 
volume of Trypan blue and serum-free medium. Each 
flask had two repeats of counting. The experiment was 
repeated three times.
QUANTIFICATION OF APOPTOSIS BY FLOW CYTOMETRY
The apoptosis rate of osteosarcoma MG-63 cells was 
quantified by flow cytometry after treating the cells in a 
t-25 flask. To harvest the cells, accutase was used with 
centrifugation, washed with cold PBS, stained with 1 μL 
annexin-V-FITC and 5 μL propidium iodide (PI) protected 
from light according to the manufacturer’s protocol 
(BD Biosciences, San Jose, CA, USA) and then analysed 
with Becton FACSC flow cytometer (Becton Dickinson 
Corporation, USA). For each condition, 1×104 cells were 
studied in each experiment.
GENE EXPRESSION
The expression of mRNA for caspases 3, 8, 9, heat shock 
protein 27 and 70 was determined by RT2 Profiler PCR 
Array system. For cDNA and genomic elimination, the RT2 
First Strand Kit (Qiagen, Germany) was used. A mixture 
containing 1 μg RNA was used for genomic elimination and 
cDNA synthesis as mentioned in the protocol. The prepared 
cDNA was added to the RT2 SYBR Green qPCR Master Mix 
(Qiagen, Hilden, Germany). An amount of 25 uL of master 
mix was loaded onto the Custom RT² PCR Array plate for 
amplifying by using the iQ™5 Real-Time PCR detection 
system (Bio-Rad, USA). GAPDH and HPRT1 were used as 
reference genes. Data analysis was performed online using 
the student’s t-test from three biological replicates (http://
www.sabiosciences.com/pcrarraydataanalysis.php).
CASPASES ACTIVITY
MG-63 cells (5×103 cell/well), in DMEM/F12 and 10% FBS, 
and 1% pen-strep were plated in the white 96-well plate 
(SPL Life Sciences, Pocheon, Gyeonggi-do, Korea) and 
left overnight to allow the cells to attach. The media were 
changed with a fresh medium contains berberine chloride 
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80 ug/mL. DMSO was added as a vehicle control to the 
control group and groups treated with hyperthermia. The 
cells were treated as mentioned previously. Activity of 
caspases 3/7, 8, and 9 was estimated using luminescence 
based assay, Caspase-Glo 3/7 Assay, Caspase-Glo 8 Assay, 
and Caspase-Glo 9 from Promega (Madison, Wisconsin, 
USA). In short, after the treatment time, the reagent (100 uL) 
was added to white-well 96 well plates and incubated for 30 
min at room temperature before performing luminescence 
reading. The luminometer was used Perkin-Elmer Victor 
X5 (Perkin Elmer, Waltham, MA, USA). Background 
reading was determined from wells containing medium 
alone and subtracted from all wells. The average result 
was calculated from three replicates.
ENZYME-LINKED IMMUNOSORBENT ASSAY
Heat shock proteins 90 alpha (Hsp90α) was obtained 
from eBioscience (San Diego, CA USA), heat shock 
protein 70 (Hsp70) from Abcam, (Cambridge, England, 
UK) and heat shock protein 27 (Hsp27) from Assaypro 
(UK) were measured by ELISA commercial kit according 
to the manufacturers’ instructions. In brief, floating and 
attached cells were harvested, washed with ice cold PBS 
and lysed in 150 uL lysis buffer containing Halt Protease 
Inhibitor Cocktail (Thermo Scientific, USA). Protein 
extraction was stored in -80°C. Protein was quantified by 
NanoDrop 1000 Spectrophotometer (Thermo Scientific, 
USA) and standardised concentration was used for all the 
samples. The obtained absorbance for samples blanks and 
standards were measured by a plate reader Perkin-Elmer 
Victor X5 multilabel reader (Perkin Elmer, Waltham, MA, 
USA). The samples optical density (OD) was compared to 
a standard curve using an online website to get the protein 
concentration (http://elisaanalysis.com/app).
STATISTICAL ANALYSIS
SPSS V.22 statistical software and Excel 2010 were used 
for the statistical analysis and graphical assessments. 
Statistical tests were performed using the student’s t-test 
and one-way ANOVA with Tukey’s posthoc tests after 
running a normality test. The results are presented as means 
± SD, and all measurements and analyses were carried out 
in triplicate.
RESULTS
THE CYTOTOXICITY OF BERBERINE ON MG-63 HUMAN 
OSTEOSARCOMA CELLS
Figure 1 shows the cell viability of MG-63 human 
osteosarcoma cells that was measured after treatment with 
several doses of berberine chloride (0-200 µg/mL) for 24 
h. The response of MG-63 cells to berberine chloride was 
dose-dependent. 80 µg/mL was chosen as a low toxic dose 
(viability 86.8%) to investigate the response of MG-63 
human osteosarcoma cells to berberine chloride alone and in 
combination with mild, moderate and severe hyperthermia.
BERBERINE, MODERATE AND SEVERE               
HYPERTHERMIA-INDUCED APOPTOSIS
Figure 2 shows that the cell viability of the berberine group 
(37°C+berberine) dropped to 83.7%. The measured cell 
viability of MG-63 cells after exposure to mild, moderate, 
and severe hyperthermia (39, 43, and 45°C) was 93.5, 89.3, 
and 83.6%, respectively, while the combined treatment of 
hyperthermia with berberine caused a significant reduction 
of cell viability to 89.5, 82, and 85.9%, respectively when 
compared to the 37°C control of 94.1%. Comparing 45°C 
alone with 45°C combined with berberine, the viability 
increased slightly to 85.9%.
 Comparing cell viability between berberine treatment 
alone at 37°C and combination groups shows that in 
berberine groups, viability was 83.7%, and no significant 
difference was observed, except that mild hyperthermia 
combined with berberine showed a significant increase 
compared to the berberine group (89.5%, p<0.001). This 
shows that mild hyperthermia attenuated the cytotoxicity 
of berberine. Figure 2 also shows that only moderated 
hyperthermia reduced cell viability from 89.3% to 82% 
after combining with berberine (p<0.001) but no significant 
increase in the rate of apoptosis.
FIGURE 1. Effect of berberine chloride on the cell viability of MG63 cells. Cell viability after berberine incubation for 24 h was 
determined using trypan blue staining. Viability was expressed as mean percent of viable cells ±SD of three biological replicates. 
Statistical analysis by Student’s t-test showed significant *p<0.05, * * p<0.01 and ***p<0.001 versus unstimulated control group
**
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HYPERTHERMIA AND BERBERINE SUPPRESSED CASPASE 
EXPRESSION AND ACTIVATION
Figure 3(A) shows the biological effect of hyperthermia 
and berberine chloride on effectors caspases. Both 
treatments, separate and in combination, did not result 
in a significant increase in caspase 3/7 activity compared 
with untreated control. Caspase 8 was downregulated in all 
groups while caspase 9 showed significant down-regulation 
in all groups, except those treated with 39 and 45°C were 
down-regulated, but the differences were not significant. 
The mRNA for caspases 3, 8, 9 were down-regulated 
(Figure 3(B)).
MODERATE AND SEVERE HYPERTHERMIA INDUCED Hsp 27 
AND Hsp70 EXPRESSION
Berberine alone incubated at body temperature (37°C) 
did not affect the cellular protein expression of Hsp90α 
and 70 while it downregulated the expression of Hsp27. 
Mild hyperthermia showed the same pattern: No effect 
on the expression of Hsp90α and 70 and downregulation 
of Hsp27. Moderate and severe hyperthermia applied 
alone, significantly upregulated the expression of Hsp27 
and 70 in osteosarcoma cells while severe hyperthermia 
additionally downregulated the expression of Hsp90α. 
When combining moderate and severe hyperthermia 
with berberine, the same pattern of expression of the 
heat shock proteins was observed: Increased expression 
of Hsp70 and Hsp27 when compared with control. 
Moderate hyperthermia in combination with berberine 
showed downregulation of Hsp90α expression compared 
with control and berberine alone. Severe hyperthermia 
with berberine further reduced the expression of Hsp90α 
when compared with severe hyperthermia alone. In the 
moderate hyperthermia plus berberine group, a reduction 
of Hsp70 and 27 was observed when compared with 
moderate hyperthermia alone. However, the protein 
levels did not reach the level of the untreated control 
cells (Figure 4(A)).
 The gene expression results showed that Hsp70 
was decreased in 37°C combined with berberine, mild 
hypothermia combined with berberine, whereas severe 
hyperthermia showed a two-fold increase with significant 
value when applied alone (p<0.01) as shown in Figure 
4(B). Interestingly, we observed that groups treated with 
berberine in combination with hyperthermia caused more 
reduction in gene expression of Hsp70. On the other hand, 
Hsp27 mRNA decreased in all groups except that moderate 
hyperthermia (43°C) showed a slight increment.
DISCUSSION
Apoptosis is a process that regulates cell turnover. It is 
also known as programmed cell death. Apoptosis takes 
place in both pathological and physiological conditions. 
It plays a vital biological role in processes such as tissue 
homeostasis, embryonic development and cell proliferation 
(Elmore 2007). The current study found that moderate and 
severe hyperthermia resulted in the induction of apoptosis 
in osteosarcoma cells separately and in combination with 
berberine chloride. These results are consistent with a 
previous study on osteosarcoma cells involving MG-63 
(Trieb et al. 2007). The combination of mild hyperthermia 
with berberine decreased the berberine toxicity significantly 
compared to cells treated with berberine alone, whereas 
severe hyperthermia combination led to a slight decrease 
of berberine toxicity. On the other hand, moderate 
hyperthermia enhanced berberine toxicity slightly. 
 When investigating drug-drug interactions, or in this 
case antioxidant-treatment interactions, it is not always 
clear what effects what. Zaidi et al. (2004) found that 
whole-body mild hyperthermia (39°C, 1 h) impaired 
radiation-induced apoptosis in mice. Bagewadikar et 
FIGURE 2. Berberine and hyperthermia induced apoptosis of MG-63 cells. Data represents the mean percentage of viable, early and 
late apoptotic cells ± SD (n=3). Using Student’s t-test the significance was set as *p<0.05, * * p<0.01, ***p<0.001 when comparing 
treatment with 37°C (control). #p< 0.001. vice 37°C+ berberine using One-way ANOVA with Tukey’s posthoc tests. 




FIGURE 4. (A) Moderate and severe hyperthermia induced Hsp70 and Hsp27 expression (B.) Severe hyperthermia induced Hsp70 
mRNA expression. The analysis was performed by RT2 Profiler PCR Array System. Data represents the mean fold change (n=3). 
Statistical analysis by Student’s t-test showed significant *p<0.05, * * p<0.01 and ***p<0.001 versus unstimulated control groups
A
B
FIGURE 3. (A) Hyperthermia and berberine chloride supressed activity of caspases 3/7, 8 and 9. (B) Hyperthermia  and berberine 
chloride supressed mRNA of caspase 3,8 and 9. PCR array was used to measure mRNA levels. Data are expressed as means (n=3). 





al. (2001) reported that prior whole-body hyperthermia 
treatment could effectively reduce N-methyl-N’-nitro-N-
nitrosoguanidine (MNNG) cytotoxicity in mice. Our results 
are consistent with these studies. Hence, mild hyperthermia 
(39°C) reduced the apoptotic rate of MG-63 cells exposed 
to berberine by around 6%. Upon combining moderate 
and severe hyperthermia with berberine, the rate of cell 
viability showed no significant difference compared with 
the group treated with berberine alone. Furthermore, 
moderate hyperthermia sensitised the cells for berberine 
chloride, but the differences in cell viability were not 
significant compared with the group treated with berberine 
alone.
 Caspases are specific cysteine-dependent aspartate-
directed proteases, or cysteine-aspartic proteases are a 
group of 12 different cysteine proteases. They can be 
subdivided into initiator, executioner and inflammatory 
caspases which play essential roles in cell death and 
inflammation (McIlwain et al. 2013). Initiator caspases (8 
and 9) activate executioner caspases (caspase-3 and 7) that 
coordinate their activities to demolish critical structural 
proteins and to activate other enzymes, leading to apoptosis 
(Degterev et al. 2003). On the other hand, increased levels 
of HSPs have been found in tumour cells where they are 
involved in various mechanisms including carcinogenesis, 
cell proliferation and survival. 
 It has been reported that overexpression of Hsp70 
inhibits many pathways of cell death (Murphy 2013). 
Hsp27 plays many physiological roles such as suppression 
of apoptosis and defence against oxidative stress 
(Mymrikov et al. 2011). Additionally, Hsp90 represents 
an attractive target for cancer treatment because of its 
role in stabilising many client oncoproteins (Gallerne et 
al. 2013). In the present study, at the protein level, Hsp70 
and Hsp27 were significantly upregulated in moderate 
and severe hyperthermia and their combined groups, 
whereas Hsp90α was downregulated in all groups except 
in moderate hyperthermia. 
 In summary, this significant increase of HSPs 
expression might explain the absence of the synergetic or 
additive apoptotic effect when berberine was combined 
with moderate and server hyperthermia. Caspase 3, 8, and 
9 were suppressed in all groups at transcription levels. 
The activity of caspases 3/7 showed a slight reduction in 
mild and moderate hyperthermia. Taken together, these 
results may indicate caspase-independent apoptosis. Wang 
et al. (2012) reported that berberine induces caspase-
independent cell death in colon tumour cells. The results 
of our study are consistent with this study. Some studies 
reported that ROS generation mediates berberine-induced 
apoptosis in human cancer cells (Chen et al. 2009; Meeran 
et al. 2008; Xie et al. 2015). Another study reported that 
berberine was able to induce apoptosis and DNA damage 
of MG-63 cells (Zhu et al. 2014). According to this finding, 
the significant induction of heat shock proteins under 
hyperthermia suggests a protective mechanism by which 
HSPs repair DNA damage (Sottile & Nadin 2017). Based 
on these studies, the attenuated toxicity of berberine or 
absence of a significant synergistic effect in the present 
study could be attributed to the significant induction of 
HSPs proteins by mild and severe hyperthermia. 
CONCLUSION
These findings raise concerns for clinical use of mild 
hyperthermia. Furthermore, low doses of berberine 
chloride have no significant additive toxic effect in 
combination with moderate and severe hyperthermia, and 
therefore, may be safe at low doses to be taken together 
with hyperthermia therapy to reduce the bystander effect 
of the treatment. Further studies are recommended to 
determine the protective mechanism of mild hyperthermia 
against berberine chloride.
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